| NCT02948933
| Cohort Event Monitoring for Dengvaxia®, CYD-TDV Dengue Vaccine | No drug interventions | Not Available | Not Available | active_not_recruiting |
| NCT02824198
| Immunogenicity and Safety of a Tetravalent Dengue Vaccine Booster Injection in Subjects Who Previously Completed a 3-dose Schedule | | prevention | 2 | completed |
| NCT00880893
| Study of Sanofi Pasteur's CYD Dengue Vaccine in Healthy Subjects in Singapore | | prevention | 2 | completed |
| NCT03432442
| Pharmacokinetics and Pharmacodynamics of Ivermectin in Pediatric Dengue Patients | | treatment | 2 | completed |
| NCT02992418
| Study of a Tetravalent Dengue Vaccine Administered Concomitantly or Sequentially With Adacel® in Healthy Subjects | | prevention | 3 | terminated |
| NCT01411241
| Study of a Booster Injection of Pentaxim™ Vaccine Administered With Dengue Vaccine in Healthy Toddlers | | prevention | 3 | completed |
| NCT02628444
| Immunogenicity and Safety of Different Vaccination Schedules of Tetravalent Dengue Vaccine in Healthy Subjects 9 to 50 Years of Age | No drug interventions | prevention | 2 | completed |
| NCT01488890
| Immune Response to Different Schedules of a Tetravalent Dengue Vaccine Given With or Without Yellow Fever Vaccine | No drug interventions | prevention | 2 | completed |
| NCT01187433
| Study of CYD Dengue Vaccine in Healthy Children and Adolescents in South America | No drug interventions | prevention | 2 | completed |
| NCT00788151
| Study of ChimeriVax™ Tetravalent Dengue Vaccine in Healthy Peruvian Children Aged 2 to 11 Years | No drug interventions | prevention | 2 | completed |
| NCT01983553
| Long-Term Study of Hospitalized Dengue & Safety in Thai Children Included in a Tetravalent Dengue Vaccine Efficacy Study | No drug interventions | Not Available | Not Available | completed |
| NCT00993447
| Immunogenicity and Safety of Sanofi Pasteur's CYD Dengue Vaccine in Healthy Children and Adolescents in Latin America | No drug interventions | prevention | 2 | completed |
| NCT02741128
| Safety and Immunogenicity of a Tetravalent Dengue Vaccine in HIV-Positive Adults | No drug interventions | prevention | 2 | completed |
| NCT01477671
| Prospective Dengue Seroprevalence Study in 5 to 10 Year-old Children | No drug interventions | Not Available | Not Available | completed |
| NCT00919178
| Safety of and Immune Response to DEN4 Vaccine Component Candidate for Dengue Virus | No drug interventions | prevention | 1 | completed |
| NCT00730288
| Study of ChimeriVax™ Dengue Tetravalent Vaccine in Adult Subjects | No drug interventions | prevention | 2 | completed |
| NCT04048837
| Prospective Study for the Evaluation of Dengue Prognostic Biomarkers in Singapore | No drug interventions | Not Available | Not Available | completed |
| NCT01064141
| A Study of Dengue Vaccine in Healthy Toddlers Aged 12 to 15 Months in the Philippines | No drug interventions | prevention | 2 | completed |
| NCT00875524
| Study of ChimeriVax™ Tetravalent Dengue Vaccine in Healthy Subjects | No drug interventions | prevention | 2 | completed |
| NCT01374516
| Study of a Novel Tetravalent Dengue Vaccine in Healthy Children and Adolescents Aged 9 to 16 Years in Latin America | No drug interventions | prevention | 3 | completed |
| NCT01436396
| Study of Yellow Fever Vaccine Administered With Tetravalent Dengue Vaccine in Healthy Toddlers | No drug interventions | prevention | 3 | completed |
| NCT00468858
| A Study of Two Doses of WRAIR Dengue Vaccine Administered Six Months Apart to Healthy Adults and Children | No drug interventions | prevention | 2 | completed |
| NCT02979535
| Immunogenicity and Safety of a Tetravalent Dengue Vaccine Administered Concomitantly or Sequentially With Cervarix® | No drug interventions | prevention | 3 | completed |
| NCT01134263
| Study of a Tetravalent Dengue Vaccine in Healthy Adults in Australia | No drug interventions | prevention | 3 | completed |
| NCT01254422
| Study of a Tetravalent Dengue Vaccine in Healthy Children Aged 2 to 11 Years in Malaysia | No drug interventions | prevention | 3 | completed |
| NCT02623725
| Study of a Booster Dose of a Tetravalent Dengue Vaccine in Subjects Who Previously Completed the 3-dose Schedule | No drug interventions | prevention | 2 | completed |
| NCT01943825
| Immunologic Mechanisms of Immune Interference and/or Cross-Neutralizing Immunity After CYD Tetravalent Dengue Vaccine | No drug interventions | prevention | 2 | completed |
| NCT00842530
| Efficacy and Safety of Dengue Vaccine in Healthy Children | No drug interventions | prevention | 2 | completed |
| NCT02993757
| Immunogenicity and Safety of a Tetravalent Dengue Vaccine Administered Concomitantly or Sequentially With Gardasil® | No drug interventions | prevention | 3 | completed |
| NCT00458120
| Safety of and Immune Response to Two Different Dengue Virus Vaccines in Individuals Previously Immunized Against Dengue Virus | No drug interventions | prevention | 1 | completed |
| NCT01550289
| Study of a Tetravalent Dengue Vaccine in Healthy Adult Subjects Aged 18 to 45 Years in India | No drug interventions | prevention | 2 | completed |
| NCT00617344
| Immunogenicity and Safety of Three Formulations of Dengue Vaccines in Healthy Adults Aged 18 to 45 Years in the US | No drug interventions | prevention | 2 | completed |
| NCT01373281
| Study of a Novel Tetravalent Dengue Vaccine in Healthy Children Aged 2 to 14 Years in Asia | No drug interventions | prevention | 3 | completed |
| NCT00740155
| Safety and Immunogenicity of Formulations of Dengue Vaccines in Healthy Flavivirus-Naïve Adults | No drug interventions | prevention | 2 | completed |
| NCT01601613
| Activated Recombinant Human Factor VII in Patients With Dengue Haemorrhagic Fever | | treatment | 2 | completed |
| NCT02827162
| Association of Host Genetics With Vaccine Efficacy and Study of Immune Correlates of Risk From a Tetravalent Dengue Vaccine | No drug interventions | Not Available | Not Available | completed |